This text first appeared on GuruFocus.
Income: $10.4 billion in Q3, up 4% year-over-year, 5% natural development.
Phase Working Margin: Elevated to 12.3% in Q3, up 80 foundation factors.
Earnings Per Share (EPS): $7.67, a ten% enhance year-over-year.
Free Money Movement: Elevated by 72% year-over-year in Q3.
E book-to-Invoice Ratio: 1.17 for the quarter.
Natural Development Fee: 5% year-over-year.
Worldwide Development Fee: 32% year-over-year.
Aeronautics Gross sales: $3.1 billion, up 6% year-over-year.
Protection Methods Gross sales: Almost $2.1 billion, up 14% year-over-year, 19% natural development.
Mission Methods Gross sales Development: Double-digit development pushed by microelectronics applications.
House Methods Gross sales: $2.7 billion, sequential development, mid-single-digit decline year-over-year.
Working Revenue Enhance: 11% year-over-year in Q3.
Steerage for 2025 Income: Revised to $41.7 billion to $41.9 billion.
2026 Free Money Movement Outlook: $3.1 billion to $3.5 billion.
Launch Date: October 21, 2025
For the entire transcript of the earnings name, please check with the full earnings name transcript.
Northrop Grumman Corp (NYSE:NOC) achieved mid-single-digit development and expanded its section working margin within the third quarter of 2025.
The corporate reported a powerful book-to-bill ratio of 1.17, indicating sturdy demand for its services and products.
Worldwide development was significantly sturdy, with a 32% enhance 12 months over 12 months, contributing to a 20% year-to-date development in worldwide gross sales.
The B-21 program made vital progress, with the second plane coming into flight take a look at and discussions underway to speed up manufacturing charges.
Northrop Grumman Corp (NYSE:NOC) elevated its free money move by 72% 12 months over 12 months, aligning with its long-term monetary outlook.
The corporate revised its full-year income steering downward as a result of delayed timing on sure awards and applications.
The House section confronted challenges with income development as a result of wind down of two massive applications.
Increased than anticipated prices have been incurred in producing the EMD flight take a look at plane for the B-21 program.
The US authorities shutdown posed potential dangers for additional delays in program awards and funding.
There are ongoing provide chain issues, significantly associated to uncommon earths, which might affect future operations.
Q: Are you able to present extra colour on the potential affect of F/A-XX and B-21 acceleration in your 2026 outlook? A: Kathy Warden, CEO, defined that neither F/A-XX nor B-21 acceleration is included within the 2026 outlook. Profitable the F/A-XX would enhance income however may be dilutive to earnings as a result of its improvement nature. The B-21 ramp would additionally enhance gross sales however require funding, with potential long-term returns. Steerage will likely be up to date if readability on these alternatives is achieved.
